World Health Organization. WHO coronavirus disease (COVID-19) dashboard 2022 [21 July 2022]. Available from: https://covid19.who.int/.
Centers for disease control and prevention. Risk for COVID-19 infection, hospitalization, and death by age group 2022 [21 July 2022]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-age.html.
Centers for disease control and prevention. Underlying medical conditions associated with high risk for severe COVID-19: Information for healthcare providers 2022 [21 July 2022]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html.
Centers for Disease Control and Prevention. Science brief: Evidence used to update the list of underlying medical conditions that increase a person's risk of severe illness from COVID-19 2022 [21 July 2022]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/underlying-evidence-table.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fhcp%2Fclinical-care%2Funderlying-evidence-table.html.
Sorensen RJ, Barber RM, Pigott DM, Carter A, Spencer CN, Ostroff SM, Reiner RC Jr, Abbafati C, Adolph C, Allorant A. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: A systematic analysis. Lancet. 2022;399(10334):1469–88.
World Health orgnization. International agency for research on cancer. global cancer observatory. colorectal cancer incidence and mortality statistics worldwide and by region 2022 [02 January 2022]. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/10_8_9-Colorectum-fact-sheet.pdf.
Balzora S, Issaka RB, Anyane-Yeboa A, Gray DM II, May FP. Impact of COVID-19 on colorectal cancer disparities and the way forward. Gastrointest Endosc. 2020;92(4):946–50.
PubMed PubMed Central Article Google Scholar
Bernard A, Cottenet J, Bonniaud P, Piroth L, Arveux P, Tubert-Bitter P, Quantin C. Comparison of cancer patients to non-cancer patients among covid-19 inpatients at a national level. Cancers. 2021;13(6):1436.
CAS PubMed PubMed Central Article Google Scholar
Collaborative C, Glasbey JC, Nepogodiev D, Simoes JF, Omar OM, Venn ML, Evans JP, Futaba K, Knowles CH, Minaya-Bravo A. Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic. Colorectal Dis. 2021;23(3):732–49.
Larfors G, Pahnke S, State M, Fredriksson K, Pettersson D. Covid-19 intensive care admissions and mortality among swedish patients with cancer. Acta Oncol. 2021;60(1):32–4.
CAS PubMed Article Google Scholar
Ma J, Yin J, Qian Y, Wu Y. Clinical characteristics and prognosis in cancer patients with COVID-19: a single center’s retrospective study. J Infect. 2020;81(2):318.
CAS PubMed PubMed Central Article Google Scholar
McCarthy K, Myint PK, Moug S, Pearce L, Braude P, Vilches-Moraga A, Hewitt J, Carter B. Letter to colorectal disease: resumption of elective colorectal surgery during COVID-19 and risk of death. colorectal disease: the official journal of the association of coloproctology of great britain and Ireland. 2020.
Ospina AV, Bruges R, Mantilla W, Triana I, Ramos P, Aruachan S, Quiroga A, Munevar I, Ortiz J, Llinás N. Impact of COVID‐19 Infection on patients with cancer: experience in a latin American Country: The ACHOCC‐19 Study. The Oncologist. 2021.
Özdemir N, Dizdar Ö, Yazıcı O, Aksoy S, Dede DS, Budakoğlu B, Metan G, Alp A, Budakoğlu II, Öksüzoğlu ÖBÇ. Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish national registry data. Int J Cancer. 2021;148(10):2407–15.
Wang J, Song Q, Chen Y, Wang Z, Chu Q, Gong H, Cai S, Dong X, Xu B, Hu W. Systematic investigations of COVID-19 in 283 cancer patients. medRxiv. 2020.
Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, Lu H, Liu J, Yang J, Dong Y. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):904–13.
CAS PubMed PubMed Central Article Google Scholar
Liu C, Wang K, Li L, Lv Q, Liu Y, Hu T, Trent JC, Sun B, Hu Q. Severity of COVID-19 in Cancer patients versus patients without cancer: a propensity score matching analysis. J Cancer. 2021;12(12):3558.
PubMed PubMed Central Article CAS Google Scholar
Várnai C, Palles C, Arnold R, Curley HM, Purshouse K, Cheng VW, Booth S, Campton NA, Collins GP, Hughes DJ. Mortality among adults with cancer undergoing chemotherapy or immunotherapy and infected with COVID-19. JAMA Netw Open. 2022;5(2):220130.
Leite H, Lindsay C, Kumar M. COVID-19 outbreak: implications on healthcare operations. TQM J. 2020.
Whittaker TM, Abdelrazek ME, Fitzpatrick AJ, Froud JL, Kelly JR, Williamson JS, Williams GL. Delay to elective colorectal cancer surgery and implications for survival: a systematic review and meta‐analysis. Colorectal Disease. 2021.
Sundaram S, Olson S, Sharma P, Rajendra S. A Review of the Impact of the COVID-19 pandemic on colorectal cancer screening: implications and solutions. Pathogens. 2021;10(11):1508.
CAS PubMed PubMed Central Article Google Scholar
Mazidimoradi A, Tiznobaik A, Salehiniya H. Impact of the COVID-19 pandemic on colorectal cancer screening: a systematic review. J Gastrointest Cancer. 2021:https://doi.org/10.1007/s12029-021-00679-x.
Al-Shamsi HO, Coomes EA, Alrawi S. Screening for COVID-19 in asymptomatic patients with cancer in a hospital in the United Arab Emirates. JAMA Oncol. 2020;6(10):1627–8.
PubMed PubMed Central Article Google Scholar
Antikchi MH, Neamatzadeh H, Ghelmani Y, Jafari-Nedooshan J, Dastgheib SA, Kargar S, Noorishadkam M, Bahrami R, Jarahzadeh MH. The risk and prevalence of COVID-19 infection in colorectal cancer patients: a systematic review and meta-analysis. J Gastrointest Cancer. 2021;52(1):73–9.
CAS PubMed Article Google Scholar
Berger JM, Gansterer M, Trutschnig W, Bathke AC, Strassl R, Lamm W, Raderer M, Preusser M, Berghoff AS. SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic. Wien Klin Wochenschr. 2021;133(17):909–14.
CAS PubMed PubMed Central Article Google Scholar
Filipe M, de Bock E, Geitenbeek R, Boerma D, Pronk A, Heikens J, Richir M. Impact of the COVID-19 Pandemic on Surgical Colorectal Cancer Care in the Netherlands: a Multicenter Retrospective Cohort Study. J Gastroint Surg 2021:1–3.
Khan R, Zaidi N, Chituku T, Rao M. Non-COVID fatalities in the COVID era: a paradigm shift in the face of a pandemic-lessons learnt (or not). Annals Med Surg. 2021;70: 102617.
Liu Y-L, Ren J, Yuan J-P, Zhang Z-J, Guo W-Y, Guan Y, Moeckel G, Ahuja N, Fu T. Postoperative onset and detection of sars-cov-2 in surgically resected specimens from gastrointestinal cancer patients with pre/asymptomatic COVID-19. Ann Surg. 2020;272(6): e321.
Mansi L, Spehner L, Daguindau E, Bouiller K, Almotlak H, Stein U, Bouard A, Kim S, Klajer E, Jary M. Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients. Eur J Cancer. 2021;150:1–9.
CAS PubMed PubMed Central Article Google Scholar
Martínez-Mardones M, Reyes G, Salas R, Fernández R, Melkonian E, Mordojovich E, Silva C, Suazo C. Strategies to advance recovery (STAR) protocol implemented colorectal cancer patients during the COVID-19 pandemic. Rev Med Chil. 2021;149(2):203–9.
Nakamura S, Kanemasa Y, Atsuta Y, Fujiwara S, Tanaka M, Fukushima K, Kobayashi T, Shimoyama T, Omuro Y, Sekiya N. Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo. Japan Int J Clinic Oncol. 2021;26(3):485–93.
Ottaiano A, Scala S, D’Alterio C, Trotta A, Bello A, Rea G, Picone C, Santorsola M, Petrillo A, Nasti G. Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection. Therapeutic Adv Med Oncol. 2021;13:17588359211011456.
Pertile D, Gipponi M, Aprile A, Batistotti P, Ferrari CM, Massobrio A, Soriero D, Epis L, Scabini S. Colorectal cancer surgery during the COVID-19 pandemic: A single center experience. in vivo. 2021;35(2):1299–305.
Quaquarini E, Saltalamacchia G, Presti D, Caldana G, Tibollo V, Malovini A, Palumbo R, Teragni CM, Balletti E, Mollica L. Impact of COVID-19 outbreak on cancer patient care and treatment: data from an outpatient oncology clinic in Lombardy (Italy). Cancers. 2020;12(10):2941.
CAS PubMed Central Article Google Scholar
Tolley T, McGregor H, Clark J, Worwood M, Stephenson B. Reported outcome measures for colorectal cancer patients during the COVID-19 pandemic. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland. 2020.
Wu Q, Chu Q, Zhang H, Yang B, He X, Zhong Y, Yuan X, Chua ML, Xie C. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors. Cancer Commun. 2020;40(8):374–9.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097.
Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2011. p. 1–12.
Greenwood D, Slack RC, Barer MR, Irving WL. Medical Microbiology E-Book: A Guide to Microbial Infections: Pathogenesis, Immunity, laboratory diagnosis and control. with student consult online Access: Elsevier Health Sciences; 2012.
DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28(2):105–14.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
PubMed PubMed Central Article Google Scholar
Aschele C, Negru ME, Pastorino A, Cavanna L, Zagonel V, Barone-Adesi F, Blasi L. Incidence of SARS-CoV-2 infection among patients undergoing active antitumor treatment in Italy. JAMA Oncol. 2021;7(2):304–6.
Ayhan M, Laçin Ş, Özyükseler DT, Sürmeli H, Doğan A, Turan M, Odabas H, Turan N, Yıldırım ME. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021:27: 10781552211015762.
Aznab M. Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic. Int J Clin Oncol. 2020;25(9):1581–6.
CAS PubMed PubMed Central Article Google Scholar
Binet Q, Goffinet C, Etogo-Asse F-E, Shaza L. Nonbacterial thrombotic endocarditis in a patient with gastric cancer and SARS-CoV-2 infection. Clinic J Gastroenterol. 2021:14(4): 1–5.
Calvo V, Fernandez-Cruz A, Nuñez B, Blanco M, Morito A, Martínez M, Traseira C, Garitaonaindía Y, Aguado R, Ramos A. Cancer and SARS-CoV-2 Infection: a third-level hospital experience. Clin Epidemiol. 2021;13:317.
PubMed PubMed Central Article Google Scholar
Cosma L, Sollaku S, Frantellizzi V, De Vincentis G. Early 18F-FDG PET/CT in COVID-19. J Med Imaging Radiat Oncol. 2020;64(5):671–3.
PubMed PubMed Central Article Google Scholar
Costanzi A, Monteleone M, Confalonieri M, Colletti G, Frattaruolo C, Fingerhut A. Late bowel iischemia and colovaginal fistula after low anterior resection in a COVID-19 patient. Chirurgia (Bucharest Romania: 1990). 2020;115(5):677–80.
Gao J, Yang M, Liu L, Guo S, Li Y, Cheng C. The aggressive surgical treatment and outcome of a colon cancer patient with COVID-19 in Wuhan. China BMC Gastroenterol. 2020;20(1):1–5.
Glasbey JC, Nepogodiev D, Simoes JF, Omar O, Li E, Venn ML, Abou C, Capizzi V, Chaudhry D, Desai A. Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study. 2021.
Haque F, Lillie P, Haque F, Maraveyas A. Deficient DNA mismatch repair and persistence of SARS-CoV-2 RNA shedding: a case report of hereditary nonpolyposis colorectal cancer with COVID-19 infection. BMC Infect Dis. 2021;21(1):1–4.
留言 (0)